Loading organizations...
§ Private Profile · Limerick, Ireland
Mavarick AI is a technology company.
Mavarick AI provides an AI-driven platform for supply chain decarbonisation, assisting manufacturers in regulated industries. Its core product automates supplier emissions data, producing audit-ready Scope 3 reports. The platform’s artificial intelligence delivers actionable insights, enabling companies to reduce carbon footprints and operational costs within supply networks.
Paul Byrnes serves as Mavarick AI’s Chief Executive Officer. The company was founded on the insight that manufacturers struggled to effectively manage intricate Scope 3 emissions data. This recognition fueled a solution translating abstract sustainability goals into concrete business outcomes, thereby streamlining environmental compliance.
Mavarick AI supports large manufacturing enterprises committed to reducing environmental impact. Its vision centers on democratizing advanced carbon intelligence via AI, providing precise analytics for verifiable decarbonisation. The company aims to integrate sustainable transformation as an achievable, economically beneficial aspect of industrial operations, fostering greener global supply chains.
Mavarick AI has raised $1.0M across 1 funding round.
Mavarick AI has raised $1.0M in total across 1 funding round.
Mavarick AI has raised $1.0M across 1 funding round. Most recently, it raised $1.0M Seed in May 2024.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| May 1, 2024 | $1M Seed | ACT Venture Capital | — | Announced |
Mavarick AI has raised $1.0M in total across 1 funding round.
Mavarick AI's investors include Act Venture Capital.
Maverick Medical AI is a technology company that develops AI-powered solutions for automating medical coding in healthcare. It builds the mCoder™ platform and CodePilot™, which provide real-time, autonomous medical coding tailored to unique practice reports, linguistics, payor mixes, regional requirements, and workflows, achieving 85%+ direct-to-bill rates and 97% accuracy. These tools serve healthcare providers, payers, and revenue cycle management companies, solving inefficiencies, errors, and high costs in the $16B medical coding market by reducing reliance on human coders and enabling physician-level analysis of patient records.[1][2]
The platform uses advanced deep learning, synthetic data, and autonomous algorithms that learn specific coding policies, deliver auditable results, and integrate frictionlessly across systems for seamless reimbursement code generation in seconds.[2]
Maverick Medical AI Corp was founded in 2019 by Yossi Shahak and Michael Brozino, both former senior executives at McKesson with over 70 years of combined experience in operations, development, and revenue generation from Fortune 15 corporations and venture-backed organizations.[1] The idea emerged to address pains in medical coding—errors, inefficiencies, and revenue challenges for providers, payers, and RCM firms—tapping into a massive market opportunity.[1] The company's digital fish logo draws from the Babel Fish in *The Hitchhiker's Guide to the Galaxy*, symbolizing its ability to instantly translate cluttered patient records into actionable insights.[1]
Early focus centered on personalized, autonomous coding, evolving into platforms like mCoder™ that surpass industry-average AI through adaptive learning.[1][2]
Maverick Medical AI rides the AI automation wave in healthcare revenue cycle management, targeting a $16B market strained by labor shortages, coding errors, and regulatory complexity.[1] Timing aligns with surging demand for AI in RCM post-2020s digital health boom, fueled by CMS updates, payor pressures, and clinician burnout—market forces favoring tools that boost direct-to-bill rates and cut costs.[1][2] It influences the ecosystem by enabling scalable, auditable automation, potentially reshaping how providers handle unstructured clinical data and accelerating AI adoption in medtech.[1][2]
(Note: A separate entity, Maverick AI LLC, focuses on agentic multimodal AI for infrastructure but lacks detailed public data and is distinct from Maverick Medical AI.[3][4])
Maverick Medical AI is poised to expand its 85%+ direct-to-bill dominance as AI maturity grows, with trends like multimodal models and real-time RCM integration shaping its path toward broader enterprise adoption. Regulatory tailwinds and synthetic data advancements could drive 95%+ automation rates, evolving its influence from coding specialist to full revenue intelligence leader—streamlining the $16B market it targeted from day one.[1][2]